[Federal Register Volume 73, Number 43 (Tuesday, March 4, 2008)]
[Notices]
[Pages 11680-11681]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 08-923]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--SAE Consortium Ltd.

    Notice is hereby given that, on January 25, 2008, pursuant to 
section 6(a) of the National Cooperative Research and Production Act of 
1993,

[[Page 11681]]

15 U.S.C. 4301 et. seq. (``the Act''), SAE Consortium Ltd. (``SAEC'') 
has filed written notifications simultaneously with the Attorney 
General and the Federal Trade Commission disclosing changes in its 
membership. The notifications were filed for the purpose of extending 
the Act's provisions limiting the recovery of antitrust plaintiffs to 
actual damages under specified circumstances. Specifically, Novartis 
Pharmaceuticals Corporation, East Hanover, NJ has been added as a party 
to this venture.
    No other changes have been made in either the membership or planned 
activity of the group research project. Membership in this group 
research project remains open, and SAEC intends to file additional 
written notification disclosing all changes in membership.
    On September 27, 2007, SAEC filed its original notification 
pursuant to section 6(a) of the Act. The Department of Justice 
published a notice in the Federal Register pursuant to section 6(b) of 
the Act on November 7, 2007 (72 FR 62867).

Patricia A. Brink,
Deputy Director of Operations, Antitrust Division.
[FR Doc. 08-923 Filed 3-3-08; 8:45 am]
BILLING CODE 4410-11-M